Evotec and Harvard stem-cell scientists partner for ALS trials – MedCity News
| MedCity News Two Harvard stem–cell scientists are teaming up with a German biotech company to expand the search for a cure for Lou Gehrig’s Disease. Harvard University professors Kevin Eggan and Lee Rubin will conduct amyotrophic lateral sclerosis trials in … |
